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The 1990s have become the decade of food safety and 
environmental awareness. The entire social contract 
between consumers, food producers and provisioners is 
in transition. From a consumer's perspective, safety, 
healthfulness, and the environmental aspects of food 
are interrelated and inseparable. The dramatic success 
of agricultural biotechnology has led to expectations 
and demands for products with desirable composition 
and food value that are safe and wholesome, and a food 
supply that is bountiful, appealing, nutritious, health­
ful, economic, convenient and safe.
In addition, as the American consumer has become 
more weight-and health-conscious, food is expected 
to impart health benefits which extend beyond mere 
nutritive value. Consumers recognize weight gain and 
its' associated effects on health as a national health 
problem. The Institute of Food Technologists (IFT) re­
cently estimated that over 34 million people in the 
United States are overweight—13 percent are described 
as severely obese. The population has evolved into a 
“lean conscious society” where a high priority is placed 
on ways to get and stay trimmer. People are more con­
cerned about exercise, consumers' diet, and food qual­
ity assisting in this change in lifestyle. This conscious­
ness is evident in the desire for leaner animal products 
with less fat and cholesterol than found in traditional 
animal products.
Along with consumers, the animal industry also 
wishes to reduce the wasteful production of excessive 
carcass fat. The current yearly production of six billion 
pounds of waste and trim fat from beef cattle is equiva-
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lent to two Iowa corn crops in feed energy, and must 
be reduced as rapidly as possible. While extensive 
trimming of animal products’ fat occurs from slaugh­
ter through to the consumer and results in a reason­
ably lean animal product, preventing excessive fat 
deposition where it occurs will minimize carcass 
waste, increase production efficiency, and effectively 
reduce the caloric content of the animal product de­
livered to consumers.
To accomplish this requires use of biotechnology in the production seg­
ments; for animals this is during stages of growth and production. A rap­
idly increasing fraction of consumers also expects foods to be further pro­
cessed and table or consumption ready, requiring new technologies in 
post-harvest segments of food production. Further, the desire for food 
safety assurance will require development and integration of sensitive 
biotechnology-based monitoring throughout all stages of producing a food 
from conception to consumption in HACCP quality assurance systems.
Role of Biotechnology in Quality and Safety of Animal Foods
The use of biotechnology will be evident in foods which are modified in 
composition or character, while technologies used to produce or to assure 
safety may not be as obvious in the food ytr si. Nonetheless, all are impor­
tant in economically producing consumer-desired products. Perhaps, in 
part, because such a small fraction of the United States population (i.e., 
less than three percent) is directly involved in production agriculture, time 
and opportunities exist to surface concerns regarding the way in which 
foods are produced.
Consumers, for several reasons, have become increasingly concerned 
about the quality and safety of the food supply, including animal derived 
foods. This reflects concerns surfaced through media and special interest 
attention to unknown risks in the environment and food supply. Consum­
ers are now questioning whether, in fact, biotechnology should even be 
used in food production. The basis for biotechnology's use in producing 
consumer-desired animal products must be explored in order to further un­
derstand these concerns.
Why Use Biotechnology in Animal Production?
The animal industry must regulate animal production in order to deliver 
consumer-desired foods and/or other required specialty (i.e., health) prod­
ucts. Appropriate technologies allow the modification of animal products
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to better fit consumers' nutritional needs and desires. Currently it is diffi­
cult sometimes to separate food from medicine since many foods contain 
components (i.e., specific types of fibers) associated with improvement in 
some body function. As opportunities arise to genetically engineer animal 
systems to produce specific needed protein compounds, such as insulin 
and other life-support proteins in milk, the distinction between medicine 
and food will become even more clouded. Biotechnology will become an 
even more important component in the modification or regulation of key 
aspects of animal production from conception of the animal through deliv­
ery to the consumer, to allow the efficient provisioning of needed animal- 
based food and health products.
Current technologies used in animal production modify growth, result­
ing in leaner products with less fat. For example, beef production incorpo­
rates anabolic implants which produce a leaner product. Emerging technol­
ogies promise similar options for pork and poultry, with applications for 
fish as well. It would be unfortunate if safe, efficacious technologies for 
producing safer and healthier consumer-desired animal products were re­
jected by consumers on the basis of misinformation through special inter­
est (i.e., vegetarian, animal rights) agendas. In assessing options for the 
use of biotechnologies, those which enhance real and/or perceived product 
quality or safety and the quality of life of the consumer are most readily ac­
cepted. Unfortunately, the value of these technologies has not been com­
municated to consumers with the same message penetration as the emo­
tional appeal for “natural” food production systems.
What Needs To Be Modified In Animal Food Products?
Food products suitable for biotechnological modification include meat, 
milk, and eggs. Many animal products currently produced may need to 
be modified to provide foods more closely aligned with contemporary nu­
trient needs and food choices of specific consumers. For many reasons, 
amounts of fat, specifically those fatty acids known to elevate cholesterol 
production (saturated with more than 16 carbons) or those known to en­
hance tumor growth (i.e., 18:2, Iinoleic), may need to be reduced in com­
mon diets in many people. Hence, appropriate changes in both fat content 
of foods and composition of fat present (fatty acids) may be desirable. 
Cholesterol levels in foods per se are not as important, because only a small 
fraction of this cholesterol is absorbed—therefore diet contributes only a 
very small fraction of the overall daily cholesterol production in humans. 
Nevertheless, consumer perceptions indicate that a reduction in choles­
terol levels in animal foods would also be desirable.
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Other modifications could also be useful. For example, the amount and 
type of protein present in foods is also important, and changes in animal 
function to produce consumer-desired types of protein (e.g., white vs. red 
meat, fiber size, etc.) would be useful. Biotechnology which reduces levels 
of natural carcinogens, or enhances levels of anti-carcinogens also would 
be important in producing animal foods which are perceived as safe. Op­
tions to accomplish this currently exist for some components (e.g., aflatox- 
ins) and have been studied or are in development for others (e.g., pesti­
cides).
Mechanisms To Modify Animal Products
Animal food products represent an integration of events ranging from ini­
tiation to harvest, and from post-harvest processing to produce, preserve 
and deliver foods to consumers. In turn, biotechnological options to mod­
ify animal products exist in all segments of production. Some key options 
include: modification of substrates used, modification of growth and sys­
temic production processes, and post-harvest product processing. These 
are accomplished in several ways and can be categorized as follows: 
feedstuff selection and processing 
digestive tract processing physiology 
physiological repartitioning 
tissue specific modification
Feedstuff Selection and Processing Although this is an area that has re­
ceived substantial attention, especially in recent years, feedstuff selection 
and processing is not a new phemomena. For quite some time, mechanisms 
which modify the fatty acid composition of animal products have been es­
tablished, particularly in animals, with minimal microbial modification of 
feeds prior to absorption. For example, the fatty acid composition of pork 
and poultry products largely reflects dietary fatty acid composition. As a 
consequence, composition of fat within some limits can be modified easily 
in meat products from these species through the selection of feed ingredi­
ents.
Once a desirable combination of fatty acids for human needs is clearly 
established, feeding-management systems can be developed to produce 
products which better reflect these needs. Challenges in the preservation 
and development of consumer-acceptable products with modified fatty 
acid composition are substantial and will provide numerous opportunities 
for biotechnology.
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Further opportunities to modify the fatty acid composition of products 
such as meat and milk from cattle and sheep are limited currently and will 
require development of novel biotechnology to make 
substantial progress. Selection and processing of feed- 
stuffs to limit microbial access to, and modification 
of, fatty acids represents an area of current interest 
and considerable challenge. Some progress with cal­
cium and other salts of fatty acids (i.e., fatty acid 
soaps) has been demonstrated and products are cur­
rently being marketed for dairy cattle, primarily to in­
crease energy intake and milk fat production with 
lesser emphasis on modification of milk fat composi­
tion. Further development of related biotechnology 
will be required to produce significant modification of 
fatty acid composition of beef or lamb products.
Another area of biotechnologically important feedstuff processing is the 
development of procedures to sequester, degrade and/or limit absorption of 
natural and synthetic toxins such that safer animal products without these 
toxins can be produced consistently. For example, products developed for 
other feed uses have found application in binding aflatoxins to limit ab­
sorption in animals, thus reducing levels of toxins in products such as milk. 
Further development of this technology is encouraged, emphasizing op­
tions which limit further transfer of natural, environmental, crop produc­
tion and microbial feedstuff toxins to animal products. Such measures will 
be required to establish consumer confidence in the production of safe 
meat and milk products.
Digestive Tract Processing Physiology Much research has been con­
ducted on digestive physiology in order to understand the absorption 
mechanisms for various nutrients and substrates for metabolism. Biotech­
nological applications in two major areas may be important. One, options 
which alter the distribution or function of specific microbes in the fermen­
tative compartments of the digestive tract of ruminants may in turn alter 
the substrates delivered for use to the animal tissues. Possible modifica­
tions include: volatile fatty acids and long chain fatty acid modification 
and synthesis resulting in altered composition of fat in animal food prod­
ucts produced. Two, modification of the digestive tract conditions and pro­
cessing through pH, enzyme activity, flow rates, passage, retention time, 
and absorptive mechanisms, among others, will allow altered substrate
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delivery to the animal tissues. This will modify the 
rate and composition of animal tissue growth, pro­
ducing modified food products.
Physiological Repartitioning to Produce Leaner 
Animal Products Repartitioning of growth and the 
consequent modification of animal products has re­
ceived major attention in recent years. Repartitioning clearly provides the 
most direct and efficacious mechanism for changing the protein and fat 
content of animal tissues. The objective is to repartition the growth pat­
terns in animals to produce leaner animal products and less fat from all ani­
mals. While repartitioning is the eventual goal of many genetic engineering 
initiatives, systems employing these concepts such as transgenic animals 
are not likely to surface any time soon. A number of options are feasible in 
developing systems employing growth regulating biotechnology in several 
forms to produce leaner animal products, and these include the following:
a. Genetics
b. Endogenous regulation
intact animals
castrated-spayed
autoimmunization
c. Exogenous regulation
repartitioning agents
estrogens
zeranol
androgens (e.g., TBA) 
growth hormone 
beta-agonists
growth hormone releasing factor
Mechanisms of regulation include: priorities for protein vs. fat, redirec­
tion of nutrients, tissue mobilization, and limits for daily deposition
All options listed above have been investigated to varying degrees across 
animal species in developing targeted growth management systems to 
most efficiently produce desired leaner animal products. While genetic di­
rectives provide general targets for body and carcass composition, other 
factors really determine the extent to which these theoretical limits will 
actually be reached, or how patterns and priorities for growth will be fol­
lowed or translated into and realized as growth. In all animal types, the en­
ergy available translates genetic directives through tissue regulation into 
patterns of growth.
The objective is to re­
partition the growth 
patterns in animals to 
produce a leaner ani­
mal product and less 
fat from all animals.
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Nutrition is directly linked to rate and composition of growth in several 
ways. Available energy is used to meet maintenance needs, protein growth, 
and fat deposition, primarily in that order. Thus, composition of meat 
products reflects levels of available substrates provided relative to mainte­
nance and limits for protein growth with additional energy usually depos­
ited as fat. The magnitude of nutritionally regulated changes in body com­
position at a given weight reflect animal priorities, rates of growth and 
length of time that animals are growing at respective rates. Slower (defer­
red) growth for extended periods of time invariably results in leaner car­
casses at any selected weight. External regulation through growth-regulat­
ing biotechnology redirecting growth allows the integration of growth po­
tential with nutrient supply resulting in the desired animal products.
Repartitioning mechanisms involved in redirection of growth include: 
modification of priorities for nutrient use for protein vs. fat deposition; al­
teration of tissue turnover; modification of daily tissue deposition limits; 
and modification of nutrient supply. Eventually, growth hormone, releas­
ing factors for growth hormone, beta-agonists and/or immunization strat­
egies to remove negative feedback on growth (e.g., somatostatin) may pro­
vide additional mechanisms with which to regulate growth. These may 
work in concert with, or replace, current growth regulation technology. 
These alternatives are currently in development.
Current estrogenic growth regulators such as growth hormone, and 
beta-agonists used in development for several animal species, are effective 
repartitioning agents which modify growth by shifting nutrients from fat 
to protein accretion (Fig. 1). Also they usually enhance rate of growth as 
well, serving to further increase lean tissue production. Rate and efficiency 
of lean tissue growth are critical components in enhancing lean animal 
production through conventional animal feeding and management sys­
tems. In addition to more efficient production, they provide the opportu­
nity to regulate growth in order to tailor animal production to meet con­
sumer desires for leaner animal products. While current growth regulators 
have been used for several decades, the basis for their function has only re­
cently begun to be understood. This understanding is important for the de­
velopment of growth regulation systems which allow programmed growth 
of animals.
Recent research provides new insights into the mechanisms by which 
growth regulating biotechnologies operate in animals. Protein growth is a 
daily function, and theoretically, cellular mechanisms establish the maxi-
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Figure 1 Rate vs. composition of gain and repartitioning of nutrients from 
fat growth to protein growth vs. rate of growth.
mal rates for daily protein synthesis. In actuality, cellular limits for protein 
growth are not often reached due to physiological factors, including hor­
monal and nutritional mechanisms which set priorities limiting protein 
deposition.
Carcass animal products reflect accumulative growth from birth to 
slaughter. As a consequence, use of growth regulation biotechnologies 
from birth to slaughter provides lifetime growth regulation and provides 
the maximal redirection of nutrients from fat to protein and lean tissue 
production. The longer growth regulators are provided, the greater the in­
crease in total lean animal product with a simultaneous reduction in fat.
While several options exist for producing leaner animal products, the 
product must be acceptable, even desirable in the marketplace. Thus, the 
degree to which these production strategies impact the production of lean 
animal products must also be assessed in terms of product acceptability. 
For example, forage-fed beef, because of its darker and softer lean will not 
have the retail case shelf-life equal to that of grain fed beef. This presents a 
serious problem from the consumer acceptance standpoint. Meat from 
these carcasses is also borderline in taste acceptability.
Tissue Specific Modification Growth regulators and repartitioning 
agents function through reducing fat deposition. Since a relationship of 
fatness to marbling exists, a reduction in marbling and resulting quality
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grade can be expected when fatness is reduced. However, for example, with 
current estrogenic growth regulators, consumer acceptability, shear force, 
palatability and tenderness are altered to a lesser extent than expected 
from the reduction in fat. This reflects the greater reduction in subcutane­
ous and kidney-pelvic fat than in intramuscular or marbling fat with es­
trogenic growth regulators when nutrients are redirected from fat to lean. 
This allows carcass quality to be maintained with a lower total degree of 
fatness.
Safety Background
Growth regulators currently approved for use with beef cattle are either 
endogenous compounds already present in human and animals (e.g., estro­
gen, testosterone, or progesterone), or are compounds developed through 
biotechnology to mimic these endogenous substances (e.g., zeranol or 
trenbolone acetate). None of these compounds are ever fed to animals in 
the United States. Instead, they are placed in the ear, which does not nor­
mally enter the food chain. When used in cattle, production residues in 
meat are extremely low and lower than naturally occurring levels in meat 
from cows and bulls. Levels of hormones produced in people every day are 
many thousands to millions times greater than present in meat either 
naturally or as a result of use of a growth regulator in cattle. Also, other 
foods, especially vegetables, salad oil, etc. provide thousands of times more 
estrogen than meat from cattle, whether receiving growth regulators or 
not, and less than 10 percent of what is consumed is absorbed by hu­
mans—so the contribution from beef is truly negligible.
Growth regulators in development, including growth hormone, beta- 
agonists, growth hormone releasing factor, and immunization will be 
equally safe but also subject to public perception.
European Economic Community Safety Issues
The European Economic Community(EEC) imposed a ban on beef imports 
from the United States and other countries using anabolic growth regula­
tors commonly referred to as “hormones”. The ban was originally launched 
under the guise of “safety” issues. The directive for the ban has been adop­
ted by the EEC although all safety issues were dismissed long ago by both 
the EEC's own commission, “The Lamming Commission” and by the 
United States own regulatory agencies, the Food Safety and Inspection Ser­
vice (FSIS) branch of USDA, and FDA).
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In contrast to the United States, where biotechnol­
ogy is tightly and efficiently regulated such that no 
violative residues were found in the past four years of 
the USDA-FSIS National Residue Program, as much 
as one fourth of the beef produced in the EEC con­
tains unacceptable residues of compounds never 
cleared for use in cattle. Some of these compounds are 
known carcinogens such as DES. A safety issue exists 
with EEC beef because of the use of unapproved 
“cocktails” of many potent drugs directly injected 
into the muscle of growing cattle on EEC farms which came about as a re­
sult of bans on the use of approved products instated during the past two 
years.
While the need to 
produce leaner, 
health-promoting 
animal products has 
become painfully 
clear, the segmenta­
tion of the industry, 
and its’ divergent 
goals, objectives and 
profit centers, has re­
sulted in mixed sig­
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Current Market Signals
While the need to produce leaner, health-promoting animal products has 
become painfully clear, the segmentation of the industry, and its' divergent 
goals, objectives and profit centers, has resulted in mixed signals at best. In 
typical scenarios, incentives to produce fatter animal products often pre­
vail. Incentives for producing leaner animal products must be established 
in all segments of the industry to assure coordination of growth toward 
optimal market endpoints.
One of the major problems is the short “shelf-life" of animals nearing 
slaughter endpoints. The concept of shelf life was developed to define the 
time and/or weight interval over which an animal maintains its current 
quality or yield grade. For some animal types, shelf-life in the feedlot may 
not be appreciably longer than post-harvest shelf-life in the retail trade. 
Extending this interval would provide more flexibility in marketing, and 
animals could increase in fatness at a slower rate, so that overfeeding 
would be less deleterious to lean animal production. Repartitioning agents 
provide options for increasing the shelf life of animals.
Diet-Health Aspects of Modified Animal Products
In concert with consumer desires to be, think, and eat “leaner”, there is 
also an interest in reducing fat consumption, particularly saturated fat, 
and cholesterol levels—both dietary and circulating. The most common 
concerns are that animal products are high in calories, saturated fat, and 
cholesterol.
An average three-ounce cooked lean beef, for example, provides only 73 
mg of cholesterol, which is less than 25 percent of the American Heart 
Association’s recommendation of 300 mg per day. This average three ounce
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portion of cooked lean beef provides only 192 kcalories of energy, less than 
10 percent of a 2000 kcalorie diet. Less than half of this energy (85 kilocalo­
ries) comes from fat and the saturated fat component contributes only half 
of that. These levels of calories from fat are far below the American Heart 
Association’s recommendations of no more than 30 and 10 percent of total 
calories from fat and saturated fat, respectively. As is evident, lean animal 
products fit well within dietary guidelines; the challenge from the produc­
tion perspective is to produce inherently lean animal products which do 
not require extensive trimming along the retail chain. Opportunities for re­
duction in fat and fatty acid modification will further advance the poten­
tial to deliver consumer-tailored, safe and healthful animal products.
Implications of Social/Political Policy
Recently, the EEC proposed a ban on imports of animal products from 
countries using growth regulators. Recent data were summarized to assess 
the impact on the industry in the United States. In a summary of growth 
regulation studies at Texas A&M University, the change in net return on a 
lean retail product basis including feed, interest, implant cost, yardage and 
with an average retail product value of $2.50/Ib, averaged $96.68 per ani­
mal. This represents a net value to the United States beef industry of ap­
proximately 2.5 billion dollars with these data as above. These data are 
consistent with results of a 1987 USDA study indicating a $2.4 to $4.1 bil­
lion reduction in net return on a retail products basis if currently approved 
growth regulators were not used in the United States depending on feeding 
and marketing management alternatives. Worldwide implications would 
obviously be much greater, and this is borne out in the USDA study.
Clearly, when safe, approved, efficacious biotechnology is banned to 
serve popular, protectionist, or political purposes, only unapproved tech­
nology will be available for use. Use of approved safe growth regulators al­
lows application of biotechnology to produce leaner beef products consis­
tent with dietary and health needs of consumers. The ban on this technol­
ogy in the EEC has resulted in the delivery of fatter beef products to Euro­
pean consumers, a situation inconsistent with the needs of United States 
and other consumers.
Similar restrictions are forthcoming or are currently in place regarding 
the use of growth hormone-based technology currently in development to 
modify meat animal products (i.e., EEC) or quantity of milk produced per 
animal (as seen in Minnesota and Wisconsin).
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In producing environmentally sensitive animal products, the adoption 
of technology (such as grain feeding, ionophores) to reduce methane, or 
growth regulators to enhance lean tissue growth, reduces the methane per 
unit of beef produced. Elimination of these technologies (i.e., growth regu­
lation ban by EEC) would result in decreases in rates of lean tissue growth 
and more methane per unit of beef produced. Hence, disallowing technol­
ogy for more efficient production of meat (growth regulators by EEC) or as 
suggested for milk production (i.e., BST) would directly increase the ani­
mal contribution to global warming by requiring the production of more 
methane per unit of product, be it meat, milk, fiber or draft power. While 
the contribution of the United States beef cattle industry to annual global 
methane production (0.5 percent of total estimated production, 0.1 per­
cent of all global warming) is not outstanding, it will be important to fa­
cilitate transfer of all available technology to enhance rate and efficiency of 
growth to reduce methane emissions from beef cattle production systems 
in the United States and worldwide, to further limit the contribution of 
cattle to global warming and changing of the earth's climates.
Conclusions
Meeting the demands imposed by consumers and industry for health con­
sciousness and animal efficiency in the production of high quality, safe, 
lean, and healthful animal products requires immediate attention to the is­
sue of increasing lean tissue and reducing fat deposition in animals. The 
ability to produce highly palatable and acceptable lean animal products is 
of critical importance for the animal industry. The calorie consciousness of 
consumers requires a sincere effort on the part of the animal products in­
dustry to produce leaner animal products to meet diet and health concerns 
of an increas.. Jly perceptive consumer. Lean animal products fit well 
within dietary guidelines; the challenge is to produce animal products that 
are lean in the carcass and do not need extensive trimming along the retail 
chain to make them lean.
Unique challenges face the animal industry in the design and develop­
ment of new technologies that will allow production of lean animal prod­
ucts rather than require extensive trimming to make them lean. This will 
require development of greater lean tissue deposition throughout the life 
cycle and extensive redirection of feed energy from fat to protein growth 
through all phases of growth.
However, society is increasingly concerned about the use of chemicals 
and residues in our food supply. The animal industry must develop, com­
municate and extend the use of current and new biotechnologies and sys­
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tem to efficiently produce leaner animal products. Technologies providing 
economic return without known benefit in enhancing quality of life and/ 
or with perceived negative human health implications (e.g., residues) may 
be short-lived.
Our primary challenge is to develop systems employing current and 
new biotechnologies which will allow us to produce specific uniform prod­
ucts from diverse animal production systems in a range of designer foods.
Most importantly, we must clearly 1) define needed 
consumer attributes of specific products and then 2) 
derive targeted-integrated biotechnology based pro­
duction systems to efficiently produce these products 
in order to 3) develop more desirable products than 
currently exist in the animal products industry. Our 
total system from conception to consumption must 
be consumer driven and must focus on the final target 
product as biotechnology-production-management-marketing options 
are selected. Concurrently, all technology implemented in the production 
system must eventually be marketed to the final consumer as well; cur­
rently this is seldom accomplished. There will be increasingly limited op­
portunities to use technologies inconsistent with quality of life of consum­
ers, and in the future, both the product as well as the system used to pro­
duce it will need to be consistent with consumer needs and attitudes.
The successful development and implementation of animal products 
will depend on consumer desires and demands. While animal-product bio­
technologies have the potential to provide seemingly desirable products 
more efficiently than current systems, their introduction and development 
relies ultimately on consumer acceptance. In addition to consumer con­
cerns, consumers and developers alike need to consider carefully the social 
and economic implications of biotechnological developments.
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